Saturday, November 16, 2024
- 10:30AM-12:30PM
-
Abstract Number: 0637
Active Implementation of Low Disease Activity State as Treatment Endpoint in a Large Cohort of Adolescents and Young Adults with Childhood Onset Systemic Lupus Erythematosus
SLE – Diagnosis, Manifestations, & Outcomes Poster I- 10:30AM-12:30PM
-
Abstract Number: 0768
Addressing Gaps in Polymyalgia Rheumatica: A Systematic Literature Review
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I- 10:30AM-12:30PM
-
Abstract Number: 0023
Adenosine and Guanosine-based Oligonucleotide Attenuates Catabolic Phenotypes in Chondrocytes and Slows Progression of Surgically Induced Osteoarthritis
Osteoarthritis & Joint Biology – Basic Science Poster- 10:30AM-12:30PM
-
Abstract Number: 0244
Adjunctive Belimumab Exerts Favorable Ferritin Recovery and Survival for Post-COVID Interstitial Lung Disease in Patients with Immune Mediated Inflammatory Diseases Treated with Rituximab: A Case Series
Infection-related Rheumatic Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 0370
Adolescents’ and Providers’ Perceptions of the Transition from Pediatric to Adult Rheumatology
Patient Outcomes, Preferences, & Attitudes Poster I- 10:30AM-12:30PM
-
Abstract Number: 0749
Age at Disease Onset Influences the Clinical Phenotype and Outcome of Patients with Takayasu Arteritis: Results from a Monocentric Cohort of 167 Patients
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I- 10:30AM-12:30PM
-
Abstract Number: 0203
Agreement of Administrative Pharmacy Dispensing with Patient-Reported Use of Oral Glucocorticoids in a Rheumatoid Arthritis Cohort
Health Services Research – ACR/ARP Poster I- 10:30AM-12:30PM
-
Abstract Number: 0702
AISA 021, a Novel Calcium Channel Antagonist in Development for Raynaud’s & Systemic Sclerosis, Has Antagonistic Activity at Sodium Channel Targets for Pain Relief and Treats Scleroderma Pain Better Than Current Calcium Channel Blockers in a Phase 2A Study
Systemic Sclerosis & Related Disorders – Clinical Poster I- 10:30AM-12:30PM
-
Abstract Number: 0567
Alteration of JAK-STAT Signaling in an Axial Spondyloarthritispatient with TYK2 Variants
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I- 10:30AM-12:30PM
-
Abstract Number: 0577
AMH Titers in Women with Axial Spondyloarthritis Are Significantly Lower Compared to the General Population: An Analysis of the 10-year Follow-up of the DESIR Cohort
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I- 10:30AM-12:30PM
-
Abstract Number: 0493
An Algorithm Pipeline for Automated Metrical Analysis of Joint Swelling in Rheumatoid Arthritis via Smartphone Hand Photographs
RA – Diagnosis, Manifestations, & Outcomes Poster I- 10:30AM-12:30PM
-
Abstract Number: 0229
An Early Inflammatory Cardiac Phenotype and Association with Future Coronary Plaque Burden in Rheumatoid Arthritis
Imaging of Rheumatic Diseases Poster I: Inflammatory Arthritis- 10:30AM-12:30PM
-
Abstract Number: 0532
An Immune-molecular Signature Specifically Modulated by JAK Inhibitors Ex Vivo May Serve as a Predictor of Therapy Response In Vivo to These Drugs
RA – Treatment Poster I